Previous studies using recombinant SAA have shown that SAA can act as a chemoattractant for neutrophils and monocytes, and the chemoattractant responsiveness for SAA is higher in type 2 diabetes patients [29], [30]. Here, SAA1 is linked to type 2 diabetes mellitus.